Filter
2365
Filtered Results: 2365
Text search:
Geneva
University
Hospitals
Featured
Recommendations
249
New Publications
428
Language
Document type
No document type
1227
Studies & Reports
476
Guidelines
343
Manuals
180
Training Material
49
Strategic & Response Plan
49
Fact sheets
23
Situation Updates
7
Videos
5
Resource Platforms
3
Infographics
2
Online Courses
1
Countries / Regions
Global
93
Kenya
47
Western and Central Europe
41
South Africa
40
Ethiopia
37
Uganda
35
Nigeria
32
Africa
32
Latin America and the Carribbean
32
India
32
Sierra Leone
30
Malawi
30
Zambia
30
Eastern Europe
25
Tanzania
24
Ukraine
22
Syria
22
Liberia
22
Nepal
21
Russia
19
Ghana
17
Mozambique
17
Namibia
16
Rwanda
15
Bangladesh
15
Lesotho
14
Burkina Faso
14
Myanmar / Burma
13
Guinea
12
South–East Asia Region
11
Philippines
10
Asia
10
South Sudan
10
Brazil
9
Germany
8
Yemen
8
Botswana
8
Indonesia
8
Senegal
7
Zimbabwe
6
Cambodia
6
Congo, Democratic Republic of
6
Western Pacific Region
6
Eastern Europe and Central Asia
6
Vietnam
6
Tajikistan
5
Colombia
5
Benin
5
Albania
5
Afghanistan
5
Peru
5
Venezuela
5
Somalia
5
Eswatini/ Swaziland
5
Thailand
4
Cameroon
4
Laos
4
Haiti
4
Jordan
4
North America
4
Lebanon
4
Angola
4
Pakistan
4
Mexico
3
China
3
Kazakhstan
3
Chile
3
Armenia
3
Saudi Arabia
3
Middle East and North Africa
3
Portugal
3
East and Southern Africa
3
Sudan
3
Mali
3
Ecuador
3
Madagascar
3
North Macedonia
2
Turkey
2
Iran
2
Estonia
2
West and Central Africa
2
Jamaica
2
Côte d’Ivoire / Ivory Coast
2
Argentina
2
Sri Lanka
2
Georgia
2
Chad
2
Iraq
2
Timor Leste/ East Timor
1
Gambia
1
Togo
1
Kyrgyzstan
1
Morocco
1
Qatar
1
Bulgaria
1
Guinea-Bissau
1
Lithuania
1
Paraguay
1
Denmark
1
France
1
Tunisia
1
United Kingdom
1
Spain
1
Latvia
1
Southern Africa
1
Bolivia
1
Moldova
1
Romania
1
Greece
1
Palestine
1
Central African Republic
1
Libya
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
538
Clinical Guidelines
278
Women & Child Health
175
Public Health
170
Key Resources
135
Capacity Building
65
Pharmacy & Technologies
39
Toolboxes
Mental Health
327
HIV
177
COVID-19
168
TB
165
Disability
116
NTDs
109
AMR
86
Caregiver
83
Planetary Health
71
Ebola & Marburg
59
Pharmacy
55
Conflict
54
NCDs
51
Rapid Response
47
Global Health Education
46
Refugee
36
2.0 Rapid Response
28
Malaria
27
Natural Hazards
18
Health Financing Toolbox
18
Zika
16
Specific Hazards
11
Polio
11
Social Ethics
9
Cholera
5
Noncommunicable diseases (NCDs) (e.g., cardiovascular diseases, cancers, diabetes, and chronic respiratory diseases) and mental health conditions (e.g., Alzheimer’s disease and related dementias, depression, anxiety, autism spectrum disorders) are the world’s leading cause of preventable illness...
To guide the provision of quality palliative care services across the African region, the African Palliative Care Association (APCA) has developed a framework of core palliative care competencies that can be used by service providers, educators and other stakeholders to guide programmes development.
In the absence of a such a measure, and building on the success of developing the APCA African
Palliative Outcome Scale (POS) for adults, the African Palliative Care Association has developed the
APCA African Children’s POS. The tool has been validated across diseases, countries, settings and ...
The document provides a standardized protocol for evaluating the Early Warning Alert and Response Network (EWARN), a surveillance system used during humanitarian emergencies when regular national health surveillance may be disrupted. The purpose of EWARN is to detect outbreaks of communicable diseas...
The prevalence of chronic non-communicable diseases such as diabetes, cardiovascular diseases and cancers has been on the increase in Kenya in the recent past. This has been occasioned by changes in social and demographic situation in the country. The life expectancy...
Q3: What approaches are available to enable non-specialized health care providers to identify children with intellectual disabilities, including intellectual disabilities due to specific causes?
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
This interim guidance is for LTCF managers and corresponding infection prevention and control (IPC) focal persons in LTCF and updates the guidance published in March 2020. The objective of this document is to provide guidance on IPC in LTCFs in the context of COVID-19 to 1) prevent COVID-19-virus fr...
The Coronavirus Disease 2019 (COVID-19) has had a continuous and robust impact on world health. The resulting COVID-19 pandemic has had a devastating physical, mental and fiscal impact on the millions of people living with noncommunicable diseases (NCDs), as they have a higher risk of severe illness...
Eur Respir J 2014; 43: 24–35 | DOI: 10.1183/09031936.00113413
A living WHO guideline on drugs for covid-19
recommended
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access for clarity. The publication of the RE...
In the Region of the Americas, the leishmaniases are a group of diseases caused by various species of Leishmania, which cause a set of clinical syndromes in infected humans that can involve the skin, mucosa, and visceral organs. The spectrum of clinical disease is varied and depends on the interacti...
Mem Inst Oswaldo Cruz , Rio de Janeiro, Vol. 110 (3): 377-386, May 2015
21 août 2020
Le présent document contient les orientations destinées aux décideurs et aux professionnels de la santé publique et de la santé de
l’enfant pour l’élaboration de politiques relatives au port du masque par les enfants dans le cadre de la pandémie de COVID-19.
Research Article
Karo et al. BMC Infectious Diseases 2014, 14:148 http://www.biomedcentral.com/1471-2334/14/148
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from ...
